Related Experiment Video
Updated: Jan 19, 2026

Targeted DNA Methylation Analysis by Next-generation Sequencing
Published on: February 24, 2015
Targeted next-generation DNA sequencing identifies Notch signaling pathway mutation as a predictor of radiation
Seung Hyuck Jeon1, Eui Kyu Chie1,2, Yi-Jun Kim1
1Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Abstract:
Purpose: Identifying the association between somatic mutations and the radiation response of tumor is essential for understanding the mechanisms and practicing personalized radiotherapy. The present study aimed to discover specific genes or pathways that are associated with radiation response using targeted next-generation DNA sequencing.Material and methods: Fifty-five patients with various solid tumors whose specimen were sequenced using institutional panel which includes 148 cancer-related genes and received radiotherapy for a measurable tumor were analyzed. Patients with irradiated tumors in complete or partial remission for more than 6 months were defined as responders. Association between mutations including pathogenic single nucleotide variants and insertions/deletions in the 148 genes and 39 molecular pathways and radiation response was investigated.Results: Analyzing 17 responders and 38 non-responders, biologically effective dose (BED), but not concurrent chemotherapy, was associated with radiation response. No single gene correlated with radiation response. Mutations in Notch signaling pathway were associated with radiosensitivity after correction for multiple comparison (adjusted p = .094). When BED and Notch signaling pathway mutation were tested with logistic regression, both variables were associated with radiation response.Conclusions: Our results suggest that somatic mutations in Notch signaling pathway may be related to sensitivity to radiation, although these results should be validated in a larger and more homogeneous cohort.
Insights
Somatic mutations in the Notch signaling pathway may predict tumor radiosensitivity. This finding could advance personalized radiotherapy by identifying patients likely to respond to radiation treatment.
Area of Science:
- Oncology
- Genetics
- Radiotherapy
Background:
- Understanding tumor somatic mutations and their link to radiation response is crucial for personalized radiotherapy.
- Targeted next-generation DNA sequencing offers a method to identify genetic factors influencing treatment outcomes.
Purpose of the Study:
- To identify specific genes or molecular pathways associated with tumor response to radiotherapy.
- To investigate the association between somatic mutations and clinical outcomes in patients undergoing radiotherapy.
Main Methods:
- Targeted next-generation DNA sequencing of 148 cancer-related genes in 55 solid tumor patients.
- Analysis of mutations in 39 molecular pathways and their correlation with radiation response, defined by remission duration.
- Biologically effective dose (BED) and concurrent chemotherapy were assessed as potential influencing factors.
Main Results:
- No single gene mutation was significantly correlated with radiation response.
- Mutations in the Notch signaling pathway showed a trend towards association with radiosensitivity (adjusted p=0.094).
- Both Biologically Effective Dose (BED) and Notch signaling pathway mutations were independently associated with radiation response in logistic regression analysis.
Conclusions:
- Somatic mutations within the Notch signaling pathway may play a role in determining tumor sensitivity to radiation therapy.
- These preliminary findings warrant validation in larger, more homogeneous patient cohorts to confirm the association and clinical utility.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
08:38Targeted DNA Methylation Analysis by Next-generation Sequencing
11:11Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
06:59Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter
08:16Comparative Lesions Analysis Through a Targeted Sequencing Approach
